Form 10Q
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                   Quarterly Report Under Section 13 or 15 (d)
                     of the Securities Exchange Act of 1934

For Quarter Ended:           Feb. 28, 1997
Commission File Number:      0-11050

                              Mammatech Corporation
              ----------------------------------------------------
             (Exact name of registrant as specified in its charter)


          Florida                                          59-2181303
 ------------------------------                        ---------------------
(State or other jurisdiction of                       (I.R.S. Employer
incorporation or organization)                         Identification Number)


930 N.W. 8th Avenue, Gainesville, Florida                       32601
-----------------------------------------                      --------
(Address of principal executive offices)                      (Zip Code)


                                 (352) 375-0607
               --------------------------------------------------
              (Registrant's telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed  by  section  13 or 15 (d) of the  Securities  Exchange  Act of 1934
during the preceding 12 months (or for such shorter  period that the  registrant
was  required  to file such  reports),  and (2) has been  subject to such filing
requirements for the past ninety days. Yes   [X]    No   [ ]

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest practicable date:

                                        Number of shares outstanding on

                                                Feb. 28, 1997
                                        --------------------------------
                                             100,352,500 shares of which
                                        7,408,500 are treasury shares
TITLE OF EACH CLASS
-----------------------------
Common stock $.0001 par value


The total number of pages of this report is 11.


<PAGE>





                              Mammatech Corporation



                                      INDEX
--------------------------------------------------------------------------------

PART I.

     FINANCIAL INFORMATION                           PAGE NO.


         Item 1.  Financial Statements

         Statements of Operations for Three Months
         Ended Feb 28, 1997 and Feb. 28, 1996.....................3

         Balance Sheets for Feb 28, 1997 and
         August 31, 1996........................................4-5

         Statement of Cash Flow for the Six Months
         Ended Feb 28, 1997.......................................6

         Statement of Cash Flow for the Quarter
         Ended Feb. 28, 1996......................................7

     Notes to Financial Statements for the Quarter
     Ended Feb 28, 1997...........................................8


         Item 2.  Management's Discussion and Analysis of
     Financial Conditions and Results of Operations...............9


PART II.     OTHER INFORMATION


         Item 6.  Exhibits and Reports on Form 8-K...............10

     SIGNATURES................................................. 11






                                       -2-

<PAGE>

<TABLE>
<CAPTION>

                              Mammatech Corporation
                            Statements of Operations
                                   (Unaudited)

                            Six Months Ended    Three Months Ended


                                                             February            February               February           February
                                                               1997                1996                   1997               1996
                                                             --------            --------               --------          ----------
<S>                                                      <C>                 <C>                  <C>                 <C>          
Sales, net .......................................       $     175,512       $     149,683        $      77,629       $      77,624
                                                           -----------         -----------          -----------          ----------
Cost of sales ....................................              50,796              45,408               21,937              22,675
                                                           -----------         -----------          -----------          ----------
Gross Profit .....................................             124,716             104,275               55,692              54,949
                                                           -----------         -----------          -----------          ----------
Selling, General and .............................              92,713             139,103               39,944              73,104
Administrative
Expenses
                                                           -----------         -----------          -----------          ----------
Operating gain ...................................              32,003             (34,828)              15,748             (18,155)
(loss)
                                                           -----------         -----------          -----------          ----------
Other Income (SBIR) ..............................                                  67,699                                   40,981
Interest and
dividends ........................................               4,564               2,608                2,601               1,266
                                                           -----------         -----------          -----------          ----------
Utilization of ...................................               7,313               7,090                3,670               4,818
operating
loss carryforward
                                                           -----------         -----------          -----------          ----------
Net income before ................................              43,880              42,569               22,019              28,910
taxes
                                                           -----------         -----------          -----------          ----------
Provision for income .............................               7,313               7,090                3,670               4,818
tax
                                                           -----------         -----------          -----------          ----------
Operating loss ...................................               7,313               7,090                3,670               4,818
carryforward
                                                           -----------         -----------          -----------          ----------
Net Income (loss) ................................              36,567              35,479               18,349              24,092
                                                           -----------         -----------          -----------         -----------
Net Income (loss) ................................               .0004               .0003                .0002               .0002
per share
                                                           -----------         -----------          -----------         -----------
Weighted average .................................         100,352,500         100,352,500          100,352,500         100,352,500
shares

</TABLE>

The accompanying notes are an integral part of the financial statements.

                                       -3-

<PAGE>

<TABLE>
<CAPTION>

                              Mammatech Corporation

                                 Balance Sheets
                                                    Feb 28, 1997    Aug. 31, 1996
                                                     (Unaudited)      (Audited)
                                                    ------------    -------------

<S>                                                    <C>              <C>     
ASSETS

  Cash and Cash Equivalents ..................         $178,760         $179,651


  Accounts receivable:
    Trade ....................................           38,617           34,287
    Other ....................................            3,243            3,246
  Inventory ..................................          135,377           94,903
  Other current assets .......................             --               --

  Total Current Assets .......................          355,997          312,087

Property and equipment .......................           46,827           52,277

Other assets:


  Patents, trademarks, and
    other intangibles, net of
    accumulated amortization
    of $53,080 and $46,942
    respectively .............................            1,762            1,561


Total other assets ...........................            1,762            1,561
                                                       --------         --------

TOTAL ASSETS .................................         $404,586         $365,925
                                                       ========         ========


The accompanying notes are an integral part of the financial statements.


                                       -4-
<PAGE>

<CAPTION>

                              Mammatech Corporation
                                 Balance Sheets

                              As of August 31, 1996
                                and Feb 28, 1997
                                   (continued)

                                                       Feb. 1997        Aug 1996
                                                       ---------        --------
<S>                                                 <C>              <C>        
LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES
Accounts payable-trade .......................      $    30,626      $    21,594
Accrued payable-officer ......................            8,630            8,630
Short Term debt ..............................            2,524            3,325
Accrued expenses .............................           49,487           55,624
                                                    -----------      -----------

TOTAL CURRENT LIABILITIES ....................           91,267           89,173
                                                    -----------      -----------


COMMITMENTS
Long Term Debt ...............................            9,223            9,223
Stockholders' equity:

  Common stock, par value $.0001;
  200,000,000 shares authorized;
  100,352,500 shares issued
  and outstanding ............................      $    10,035      $    10,035

  Additional paid-in capital .................        2,809,594        2,809,594
  Accumulated deficit ........................       (2,367,482)      (2,404,049)
                                                    -----------      -----------
                                                        452,157          415,580

  Treasury stock at cost,
  6,208,500 shares ...........................         (148,051)        (148,051)
                                                    -----------      -----------
                                                        304,096          267,529
                                                    -----------      -----------

TOTAL LIABILITIES AND
STOCKHOLDERS' EQUITY .........................      $   404,586      $   365,925
                                                    ===========      ===========

</TABLE>

The accompanying notes are an integral part of these statements.


                                       -5-



<PAGE>

<TABLE>
<CAPTION>

                              Mammatech Corporation
                             Statement of Cash Flow
                            For the Six Months Ending
                                  Feb 28, 1997





<S>                                                                   <C>      
Net cash flow from operating activities ....................          $   3,341
                                                                      =========

Investing Activities:
    Purchase of furniture and fixtures .....................             (2,450)


Financing activities:
    Issuance of treasury shares ............................                -0-
Sale of marketable securities ..............................                -0-

Net increase (decrease) in cash ............................               (891)


Beginning cash .............................................            179,651
                                                                       --------
Ending cash ................................................            178,760
                                                                       ========

</TABLE>

The accompanying notes are an integral part of the financial statements.






                                       -6-



<PAGE>

<TABLE>
<CAPTION>

                              Mammatech Corporation
                             Statement of Cash Flow
                            For the Six Months Ending
                                  Feb 29, 1996





<S>                                                                   <C>      
Net cash flow from operating activities ....................          $  32,544
                                                                      =========

Investing Activities:
    Purchase of furniture and fixtures .....................             (7,916)


Financing activities:
    Issuance of treasury shares ............................                -0-
Sale of marketable securities ..............................                -0-

Net increase (decrease) in cash ............................             24,628


Beginning cash .............................................            136,702
                                                                       --------
Ending cash ................................................            161,330
                                                                       ========

</TABLE>

The accompanying notes are an integral part of the financial statements.






                                       -7-



<PAGE>


                              Mammatech Corporation
                          Notes to Financial Statements
                                  Feb 28, 1997



Note 1.   In  the opinion  of the Company,  the accompanying unaudited financial
          statements   contain  all  adjustments   (consisting  of  only  normal
          recurring accruals) necessary to present fairly the financial position
          as of Feb 28,  1997,  and the  results of  operations  and  changes in
          financial position for the three months ended Feb 28, 1997.


Note 2.   Loss  per share  is based  on the  weighted  average  number of shares
          outstanding during each period.

Note 3.   Gives  effect  to  the  Company's  repurchasing  7,558,500  shares  of
          stock from shareholders for treasury stock.

















                                       -8-



<PAGE>




MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITIONS AND RESULTS OF OPERATION FOR MAMMATECH CORPORATION


During the second quarter of fiscal 1997 the Company's sales revenues  decreased
by 21% over the previous quarter but increased by $5 compared to the same period
one year ago.  Gross profit  increased 1.4% from the second quarter of 1996, but
decreased by 19.3% in comparison to last quarter.  Operating  expense during the
current quarter relative to the first quarter  decreased by 24%,  resulting in a
3% reduction in operating gain. Net income for the quarter was down 24% compared
to a year  earlier,  but was 0.7% higher than the first quarter of 1997. A major
difference  between  this year and last year was the absence of the Phase I SBIR
grant which added both revenue and expense during 1996.

A similar picture emerges with respect to the six-month figures.  Sales revenues
increased  7% but the  operating  gain of $32,003  compared to a loss of $34,828
during  the first six  months of 1996  again  reflects  the  absence  of expense
associated  with  administering  the SBIR project.  The net result for the first
half of the year nevertheless  shows an increase of 3% compared to the first six
months of fiscal 1996.

During the second quarter,  the Company made a large sale of product to the West
Virginia  Department  of  Human  Resources  in  connection  with  that  agency's
involvement  with the  Breast  and  Cervical  Cancer  Program  of the Center for
Disease Control. The Indiana Division of the American Cancer Society also made a
substantial  purchase as they undertake to bring the MammaCare technology to the
women of that state.  Finally,  the  California  Department  of Health  Services
continues  to purchase  substantial  quantities  of special  MammaCare  products
designed to support their  experimental  program for teaching competent clinical
breast examination to community physicians.

The Company also began  negotiations with a German concern which seeks to become
the  exclusive  distributor  of MammaCare  products  throughout  Germany and the
German speaking  portions of Switzerland and Austria.  Terms and conditions have
been agreed to and the Company expects to sign the agreement in the near future.
There can be no  assurance  that  substantial  revenues  will  result  from this
association,  however,  but the  Company  believes  that the German  health care
system is an ideal outlet for MammaCare products and training services.

The Company  continues to seek other  opportunities  to expand its marketing and
manufacturing  activities  to  meet  the  growing  world-wide  interest  in  its
products.


                                       -9-



<PAGE>


PART II - OTHER INFORMATION
---------------------------



Item 6.    Exhibits and Reports on Form 8-K

   (a.)    Exhibits - None

   (b.)   There were no reports filed on Form 8-K during the three months ending
          Feb 28, 1997.














                                       -10-



<PAGE>



                                      10-Q

                     For the three months ended Feb 28, 1997

                                   Signatures

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

MAMMATECH CORPORATION
---------------------

DATE: April 7, 1997           BY: /s/ Henry S. Pennypacker
                                 -------------------------------------
                                 Henry S. Pennypacker,
                                   President and Director




BY: /s/ Mary Sellers
   ----------------------------
    Mary Sellers, Treasurer and
    Chief Financial Officer








                                       -11-